Scientific Literature Search

Source record

Cysteine elevation in levodopa-treated patients with Parkinson's disease.

Müller T, Kuhn W.

Mov Disord · 2009-04-01

DOI: 10.1002/mds.22482PMID: 19243072

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Direct costs for Parkinson's treatment in private neurology practices in Berlin].

Ehret R, Balzer-Geldsetzer M, Reese JP, Dodel I, Becker E, Christopher A, Friedrich H, Kraemer S, Lüer W, Müngersdorf M, Puzich R, Rohr A, Schultes-Platzek I, Siefjediers V, Tiel-Wilck K, Oertel WH, Dodel R.

Nervenarzt · 2009-04-01

DOI: 10.1007/s00115-009-2671-yPMID: 19252890

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Rethinking a drug treatment failure on a traditional ALS target.

Maragakis NJ.

Exp Neurol · 2009-04-01

DOI: 10.1016/j.expneurol.2008.12.025PMID: 19309797

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.

Bäumer T, Hidding U, Hamel W, Buhmann C, Moll CK, Gerloff C, Orth M, Siebner HR, Münchau A.

Mov Disord · 2009-04-01

DOI: 10.1002/mds.22417PMID: 19185021

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.

Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE.

Mayo Clin Proc · 2009-04-01

DOI: 10.1016/s0025-6196(11)60538-7PMID: 19339647

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Treatment strategies for nonmotor manifestations of Parkinson's disease.

Reichmann H, Ziemssen T.

Expert Opin Pharmacother · 2009-04-01

DOI: 10.1517/14656560902811605PMID: 19351227

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Apomorphine in the treatment of Parkinson disease and other movement disorders.

Gunzler SA.

Expert Opin Pharmacother · 2009-04-01

DOI: 10.1517/14656560902828344PMID: 19364250

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Pharmacologic treatment of Parkinson disease].

Murata M.

Brain Nerve · 2009-04-01

PMID: 19378816

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Current status of gene therapy for Parkinson disease].

Mochizuki H.

Brain Nerve · 2009-04-01

PMID: 19378818

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

New drug delivery strategies for improved Parkinson's disease therapy.

Di Stefano A, Sozio P, Iannitelli A, Cerasa LS.

Expert Opin Drug Deliv · 2009-04-01

DOI: 10.1517/17425240902870405PMID: 19382882

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Initiating therapy in Parkinson's disease.

Weiner W, Ahlskog E, Factor S, Suchowersky O, Reich S.

Ann Neurol · 2009-04-01

DOI: 10.1002/ana.21667PMID: 19399873

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement.

Toriumi H, Yoshikawa M, Matsuda R, Nishimura F, Yamada S, Hirabayashi H, Nakase H, Nonaka J, Ouji Y, Ishizaka S, Sakaki T.

Neurol Res · 2009-04-01

DOI: 10.1179/016164108x339378PMID: 19406036

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.626 articles found

Cysteine elevation in levodopa-treated patients with Parkinson's disease.

[Direct costs for Parkinson's treatment in private neurology practices in Berlin].

Rethinking a drug treatment failure on a traditional ALS target.

Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.

Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.

Treatment strategies for nonmotor manifestations of Parkinson's disease.

Apomorphine in the treatment of Parkinson disease and other movement disorders.

[Pharmacologic treatment of Parkinson disease].

[Current status of gene therapy for Parkinson disease].

New drug delivery strategies for improved Parkinson's disease therapy.

Initiating therapy in Parkinson's disease.

Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement.

Filters